Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.

Mafra CS, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, Taguchi FM, Foronda AS, Carvalho FR, de Freitas D.

Invest Ophthalmol Vis Sci. 2013 Sep 27;54(9):6363-72. doi: 10.1167/iovs.13-11990.

PMID:
23900604
3.

Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.

Pérez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK.

Ophthalmology. 2003 Aug;110(8):1593-600.

PMID:
12917179
4.
5.

The reculture technique: individualizing the treatment of Acanthamoeba keratitis.

Wysenbeek YS, Blank-Porat D, Harizman N, Wygnanski-Jaffe T, Keller N, Avni I.

Cornea. 2000 Jul;19(4):464-7.

PMID:
10928758
6.

Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.

Polat ZA, Walochnik J, Obwaller A, Vural A, Dursun A, Arici MK.

Clin Exp Ophthalmol. 2014 Mar;42(2):151-8. doi: 10.1111/ceo.12120. Epub 2013 May 21.

PMID:
23601234
7.

Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro.

Tirado-Angel J, Gabriel MM, Wilson LA, Ahearn DG.

Curr Eye Res. 1996 Feb;15(2):225-8.

PMID:
8670733
8.

Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba.

Alizadeh H, Neelam S, Cavanagh HD.

Eye Contact Lens. 2009 Jan;35(1):1-5. doi: 10.1097/ICL.0b013e3181909ae6.

9.

In vitro evaluation of the amoebicidal activity of garlic (Allium sativum) extract on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.

Polat ZA, Vural A, Ozan F, Tepe B, Ozcelik S, Cetin A.

J Ocul Pharmacol Ther. 2008 Feb;24(1):8-14. doi: 10.1089/jop.2007.0035.

PMID:
18370873
10.

Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Lamy R, Chan E, Good SD, Cevallos V, Porco TC, Stewart JM.

Clin Exp Ophthalmol. 2016 Apr;44(3):181-7. doi: 10.1111/ceo.12644. Epub 2016 Feb 23.

11.

Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear.

Lee SJ, Jeong HJ, Lee JE, Lee JS, Xuan YH, Kong HH, Chung DI, Ock MS, Yu HS.

Korean J Parasitol. 2006 Dec;44(4):313-20.

12.

Phagocytosis affects biguanide sensitivity of Acanthamoeba spp.

Noble JA, Ahearn DG, Avery SV, Crow SA Jr.

Antimicrob Agents Chemother. 2002 Jul;46(7):2069-76.

13.

Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp.

Sant'ana VP, Carrijo-Carvalho LC, Foronda AS, Chudzinski-Tavassi AM, de Freitas D, de Carvalho FR.

Graefes Arch Clin Exp Ophthalmol. 2015 Jan;253(1):65-75. doi: 10.1007/s00417-014-2783-3. Epub 2014 Aug 27.

PMID:
25161076
14.
16.

Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?

Tseng SH, Lin SC, Chen FK.

Cornea. 1998 May;17(3):345-6. No abstract available.

PMID:
9603394
17.

Aspects of the mechanisms of action of biguanides on trophozoites and cysts of Acanthamoeba castellanii.

Khunkitti W, Lloyd D, Furr JR, Russell AD.

J Appl Microbiol. 1997 Jan;82(1):107-14.

18.

[Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].

Walochnik J, Duchêne M, Eibl H, Aspöck H.

Wien Klin Wochenschr. 2003;115 Suppl 3:10-7. Review. German.

PMID:
15508774
19.

Should we be using polyhexamethylene biguanide to treat Acanthamoeba keratitis?

Kumar B, Crawford GJ.

Aust N Z J Ophthalmol. 1997 May;25(2):94-5. No abstract available.

PMID:
9267593
20.

Potential Value of Cellulose Synthesis Inhibitors Combined With PHMB in the Treatment of Acanthamoeba Keratitis.

Moon EK, Hong Y, Chung DI, Goo YK, Kong HH.

Cornea. 2015 Dec;34(12):1593-8. doi: 10.1097/ICO.0000000000000642.

PMID:
26426333

Supplemental Content

Support Center